Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
06/2008
06/25/2008EP1934378A2 Methods for diagnosing pancreatic cancer
06/25/2008EP1934331A2 Targeting pax2 for the induction of defb1-mediated tumor immunity and cancer therapy
06/25/2008EP1934240A1 Phosphate biosensors and methods of using the same
06/25/2008EP1934239A2 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
06/25/2008EP1933882A2 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
06/25/2008EP1933880A2 Oligoribonucleotides and methods of use thereof for treatment of cardiovascular diseases
06/25/2008EP1933873A2 Methods and compositions for use in treatment of patients with autoantibody positive diseases
06/25/2008EP1933864A2 Antibodies as t cell receptor mimics, methods of production and uses thereof
06/25/2008EP1933614A2 Sucrose biosensors and methods of using the same
06/25/2008EP1689849A4 Primate prokineticin and prokineticin receptor polypeptides, related compositions and methods
06/25/2008EP1670928A4 Single nucleotide polymorphism analysis of highly polymorphic target sequences
06/25/2008EP1667730A4 Compositions and methods for treating inflammatory lung disease
06/25/2008EP1660631A4 Compositions and methods for preparing short rna molecules and other nucleic acids
06/25/2008EP1430147A4 Fluorescent quenching detection reagents and methods
06/25/2008EP1173623B1 Solid medium and process for the storage and rapid purification of nucleic acid
06/25/2008EP1033996B1 Prevention and treatment of amyloidogenic disease
06/25/2008CN101208438A Method of treating an inflammatory disease by double stranded ribonucleic acid
06/25/2008CN101208437A Biosensors for detecting macromolecules and other analytes
06/25/2008CN101208427A Methods and compositions for amino acid production
06/25/2008CN101205542A Construction method of shRNA expression carrier for inhibiting core1 beta1-3 galactosyltransferase and use thereof
06/25/2008CN101205246A Nucleic acid extraction device
06/25/2008CN100397082C HCV-free-blood external preparing method
06/25/2008CN100396788C Multiplex oligonucleotide addition and target amplification
06/25/2008CN100396701C Fusion protein of extrasin alpha1 and interferon
06/25/2008CN100396692C Diuridine tetraphosphate or salt crystal thereof, process for producing the same, and process for producing the compounds
06/24/2008US7390894 Glutathione S-transferase sequence variants
06/24/2008US7390892 nucleotide sequences and genes that code for proteins as well as antibodies raised against such proteins; enzymes used in screening assays to identify antiprotozoa agents; antibodies use to protect animals from disease caused by parasites
06/24/2008US7390890 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases
06/24/2008US7390887 Antibodies against PRO4330
06/24/2008US7390886 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders
06/24/2008US7390883 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by skeletal cells/adipocytes; for stimulating the release of proteoglycans from cartilage
06/24/2008US7390881 first component is the modified antigenic ectodomain of measles virus hemagglutinin protein, second component fused to first component that binds a surface protein of human immunodeficiency virus; for treating HIV infection and other therapeutic targets against which it is difficult to develop vaccines
06/24/2008US7390880 Soluble interleukin-1 receptor accessory molecule
06/24/2008US7390879 Conjugation/biochemical; fibroblast growth factors
06/24/2008US7390878 PRO6090 polypeptides
06/24/2008US7390877 Vectors with DNA encoding pro polypeptides
06/24/2008US7390876 Identification and isolation of novel DNA and recombinant production of novel polypeptides
06/24/2008US7390872 fusion proteins has high transduction potential, inhibits the NF- kappa B pathway; biodrugs as antiinflammatory agents, viricides, antiproliferative agents, immunostimulants
06/24/2008US7390832 Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment
06/24/2008US7390792 Method of reducing Delta protein expression in a cell comprising the steps of introducing into the cell miR-1 and detecting a resultant reduction of Delta protein expression in the cell; resultant reduction is quantitatively detected
06/24/2008US7390791 Prodrugs of phosphonate nucleotide analogues
06/24/2008US7390780 For transfecting nucleic acids in vivo or ex vivo; vesicle forming lipid and hydrophilic polymer; gene therapy
06/24/2008US7390672 Each spot comprises 3-hydroxypicolinic acid matrix and no analyte, andhas an amount of the matrix resulting from deposition of a reproduced, defined and controlled nanoliter volume of a solution comprising the matrix and an evaporating solvent; diagnosis
06/24/2008US7390656 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
06/24/2008US7390655 Promoter molecules for use in plants
06/24/2008US7390654 Avoidance of undesirable replication intermediates in plasmid propagation
06/24/2008US7390643 Geranyl diphosphate synthase molecules, and nucleic acid molecules encoding same
06/24/2008US7390640 Circular permutant GFP insertion folding reporters
06/24/2008US7390638 A polynucleotide encoding a carboxy-truncated interferon gamma (IFNG) polypeptide mutant exhibiting IFNG receptor binding activity having the amino acid sequence, SEQ ID NO:12, or 1-10 residue modifications; antitumor, -carcinogenic agent; viricides; interstitial lung diseases; autoimmune diseases
06/24/2008US7390637 Keratinocyte derived interferon
06/24/2008US7390636 Method for construction and use of Kluyveromyces lactis promoter variants in K. lactis that substantially lack E. coli transcriptional capability
06/24/2008US7390634 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation
06/24/2008US7390632 Soluble ErbB3 receptor isoforms
06/24/2008US7390623 Detection and identification of staphylococcus aureus and epidermidis using the 16S-23S rRNA spacer
06/24/2008US7390622 Apparatus and methods for detecting nucleic acid in biological samples
06/24/2008US7390495 Neurovirulent strain of the West Nile virus and uses thereof
06/24/2008US7390493 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
06/24/2008US7390486 PRO4381 antibodies
06/24/2008US7390485 Genetically engineered soluble form of CD39L3 or fusion protein of soluble form with heterologous sequence; deletions and replacements; anticoagulant, antiinflammatory, antihypoxic, and antiischemic agents; atherosclerosis, arteriosclerosis, preeclampsia, strokes; cardiovascular disorders
06/19/2008WO2008073688A2 Improved expression system for recombinant human arginase i
06/19/2008WO2008073598A2 Methods for improving antibody production
06/19/2008WO2008073578A2 Plant genes involved in nitrate uptake and metabolism
06/19/2008WO2008072865A1 Method for isolating a nucleic acid using particulate matter and a composition therefor
06/19/2008WO2007117282A3 Lactic acid-producing yeast cells having nonfunctional l-or d-lactate: ferricytochrome c oxidoreductase gene
06/19/2008WO2007109321A3 Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting
06/19/2008WO2007069092B1 Cationic oligonucleotides, automated methods for preparing same and their uses
06/19/2008US20080148430 Using transgenic plants as bioreactor for measuring or detecting mitogen-activated protein (MAP) kinase activity
06/19/2008US20080146789 Methods for the separation of biological molecules using dioxolane
06/19/2008US20080146788 has a plurality of modified ribofuranosyl nucleosides at defined locations; comprise double stranded constructs wherein one of the strands capable of hybridizing to a nucleic acid target
06/19/2008US20080146787 nucleoside monomers protected with thioether substituted aryl carbonate protecting groups; oligonucleotides, using such protected nucleoside monomer monomers, as well as nucleic acids
06/19/2008US20080146781 Modified Human Four Helical Bundle Polypeptides and Their Uses
06/19/2008US20080146519 IL-14alpha RNA inhibitors and antibodies to IL-14alpha for treatment of autoimmune diseases and lymphomas
06/19/2008US20080146505 47 Human Secreted Proteins
06/19/2008US20080146503 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins
06/19/2008US20080146492 Insulin production methods and pro-insulin constructs
06/19/2008US20080146455 Methods for identification of sepsis-causing bacteria
06/19/2008US20080145935 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
06/19/2008US20080145928 Nucleotide sequences coding transcription factor for use in prevention and treatment of cell proliferative disorders
06/19/2008US20080145916 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
06/19/2008US20080145915 Hepatitis C virus vaccine
06/19/2008US20080145912 Cellulytic enzyme for use in paper making, textile treatment and laundry detergents
06/19/2008US20080145907 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces
06/19/2008US20080145897 Polymerase enhancing factor (PEF) extracts, PEF protein complexes, Isolated PEF protein, and methods for purifying and identifying
06/19/2008US20080145895 Expression vector comprising nucleotide sequences coding light and heavy chain immunoglobulin segments for use as efficient gene transfer element in genetic engineering and gene therapy
06/19/2008US20080145892 Expression vector comprising DBV gene cluster for use in transformation and synthesis of preferential peptide antibiotic
06/19/2008US20080145884 Sfrp and peptide motifs that interact with sfrp and methods of their use
06/19/2008US20080145882 Mutant hydrolase proteins with enhanced kinetics and functional expression
06/19/2008US20080145867 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition
06/19/2008US20080145850 Mass Labels
06/19/2008US20080145847 Methods for identification of sepsis-causing bacteria
06/19/2008US20080145842 Novel Test Method For Taste Abnormality
06/19/2008US20080145839 Method and Nucleic Acids For the Differentiation of Astrocytoma, Oligoastrocytoma and Oligodenroglioma Tumor Cells
06/19/2008US20080145379 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
06/19/2008US20080145377 G-CSF Polypeptides And Uses Thereof
06/19/2008US20080145369 Using pc-cell-derived growth factor concentration as diagnostic indicator of cell proliferative disorders
06/19/2008US20080145366 Platelet derived growth factor specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative disorders; antisense agents; antitumor agents
06/19/2008US20080145365 Human and mammalian stem cell-derived neuron survival factors
06/19/2008US20080145353 Perhydrolase
06/19/2008US20080145347 p-Hyde sequences in the Rat
06/19/2008US20080145339 Modified rolling circle initiator protein for use as therapeutic tool in suppression of viral replication and disorders